Induced association of μ opioid (MOP) and type 2 cholecystokinin (CCK 2) receptors by novel bivalent ligands

Yaguo Zheng, Eyup Akgun, Kaleeckal G. Harikumar, Jessika Hopson, Michael D. Powers, Mary M. Lunzer, Laurence J. Miller, Philip S Portoghese

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Both μ-opioid (MOP) and type 2 cholecystokinin (CCK 2) receptors are present in areas of the central nervous system that are involved in modulation of pain processing. We conducted bioluminescence resonance energy transfer (BRET) studies on COS cells coexpressing MOP and CCK 2 receptors to determine whether receptor heterodimerization is involved in such modulation. These studies revealed the absence of constitutive or monovalent ligand-induced heterodimerization. Heterodimerization of MOP and CCK 2 receptors therefore is unlikely to be responsible for the opposing effects between morphine and CCK in the CNS. However, association was induced, as indicated by a positive BRET signal, on exposure of the cells to bivalent ligands containing μ-opioid agonist and CCK 2 receptor antagonist pharmacophores linked through spacers containing 16-22 atoms but not with a shorter (9-atom) spacer. These studies demonstrate for the first time that an appropriately designed bivalent ligand is capable of inducing association of G-protein-coupled receptors. The finding that opioid tolerance studies with these ligands in mice showed no correlation with the BRET data is consistent with the absence of association of MOP and CCK 2 receptors in vivo.

Original languageEnglish (US)
Pages (from-to)247-258
Number of pages12
JournalJournal of Medicinal Chemistry
Volume52
Issue number2
DOIs
StatePublished - Jan 22 2009

Fingerprint

Cholecystokinin B Receptor
Cholecystokinin Receptors
Opioid Analgesics
Ligands
Energy Transfer
COS Cells
G-Protein-Coupled Receptors
Morphine
Central Nervous System
Pain

Cite this

Induced association of μ opioid (MOP) and type 2 cholecystokinin (CCK 2) receptors by novel bivalent ligands. / Zheng, Yaguo; Akgun, Eyup; Harikumar, Kaleeckal G.; Hopson, Jessika; Powers, Michael D.; Lunzer, Mary M.; Miller, Laurence J.; Portoghese, Philip S.

In: Journal of Medicinal Chemistry, Vol. 52, No. 2, 22.01.2009, p. 247-258.

Research output: Contribution to journalArticle

Zheng, Yaguo ; Akgun, Eyup ; Harikumar, Kaleeckal G. ; Hopson, Jessika ; Powers, Michael D. ; Lunzer, Mary M. ; Miller, Laurence J. ; Portoghese, Philip S. / Induced association of μ opioid (MOP) and type 2 cholecystokinin (CCK 2) receptors by novel bivalent ligands. In: Journal of Medicinal Chemistry. 2009 ; Vol. 52, No. 2. pp. 247-258.
@article{ebe24cc33daa4e85a4f4838217d0f13d,
title = "Induced association of μ opioid (MOP) and type 2 cholecystokinin (CCK 2) receptors by novel bivalent ligands",
abstract = "Both μ-opioid (MOP) and type 2 cholecystokinin (CCK 2) receptors are present in areas of the central nervous system that are involved in modulation of pain processing. We conducted bioluminescence resonance energy transfer (BRET) studies on COS cells coexpressing MOP and CCK 2 receptors to determine whether receptor heterodimerization is involved in such modulation. These studies revealed the absence of constitutive or monovalent ligand-induced heterodimerization. Heterodimerization of MOP and CCK 2 receptors therefore is unlikely to be responsible for the opposing effects between morphine and CCK in the CNS. However, association was induced, as indicated by a positive BRET signal, on exposure of the cells to bivalent ligands containing μ-opioid agonist and CCK 2 receptor antagonist pharmacophores linked through spacers containing 16-22 atoms but not with a shorter (9-atom) spacer. These studies demonstrate for the first time that an appropriately designed bivalent ligand is capable of inducing association of G-protein-coupled receptors. The finding that opioid tolerance studies with these ligands in mice showed no correlation with the BRET data is consistent with the absence of association of MOP and CCK 2 receptors in vivo.",
author = "Yaguo Zheng and Eyup Akgun and Harikumar, {Kaleeckal G.} and Jessika Hopson and Powers, {Michael D.} and Lunzer, {Mary M.} and Miller, {Laurence J.} and Portoghese, {Philip S}",
year = "2009",
month = "1",
day = "22",
doi = "10.1021/jm800174p",
language = "English (US)",
volume = "52",
pages = "247--258",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "2",

}

TY - JOUR

T1 - Induced association of μ opioid (MOP) and type 2 cholecystokinin (CCK 2) receptors by novel bivalent ligands

AU - Zheng, Yaguo

AU - Akgun, Eyup

AU - Harikumar, Kaleeckal G.

AU - Hopson, Jessika

AU - Powers, Michael D.

AU - Lunzer, Mary M.

AU - Miller, Laurence J.

AU - Portoghese, Philip S

PY - 2009/1/22

Y1 - 2009/1/22

N2 - Both μ-opioid (MOP) and type 2 cholecystokinin (CCK 2) receptors are present in areas of the central nervous system that are involved in modulation of pain processing. We conducted bioluminescence resonance energy transfer (BRET) studies on COS cells coexpressing MOP and CCK 2 receptors to determine whether receptor heterodimerization is involved in such modulation. These studies revealed the absence of constitutive or monovalent ligand-induced heterodimerization. Heterodimerization of MOP and CCK 2 receptors therefore is unlikely to be responsible for the opposing effects between morphine and CCK in the CNS. However, association was induced, as indicated by a positive BRET signal, on exposure of the cells to bivalent ligands containing μ-opioid agonist and CCK 2 receptor antagonist pharmacophores linked through spacers containing 16-22 atoms but not with a shorter (9-atom) spacer. These studies demonstrate for the first time that an appropriately designed bivalent ligand is capable of inducing association of G-protein-coupled receptors. The finding that opioid tolerance studies with these ligands in mice showed no correlation with the BRET data is consistent with the absence of association of MOP and CCK 2 receptors in vivo.

AB - Both μ-opioid (MOP) and type 2 cholecystokinin (CCK 2) receptors are present in areas of the central nervous system that are involved in modulation of pain processing. We conducted bioluminescence resonance energy transfer (BRET) studies on COS cells coexpressing MOP and CCK 2 receptors to determine whether receptor heterodimerization is involved in such modulation. These studies revealed the absence of constitutive or monovalent ligand-induced heterodimerization. Heterodimerization of MOP and CCK 2 receptors therefore is unlikely to be responsible for the opposing effects between morphine and CCK in the CNS. However, association was induced, as indicated by a positive BRET signal, on exposure of the cells to bivalent ligands containing μ-opioid agonist and CCK 2 receptor antagonist pharmacophores linked through spacers containing 16-22 atoms but not with a shorter (9-atom) spacer. These studies demonstrate for the first time that an appropriately designed bivalent ligand is capable of inducing association of G-protein-coupled receptors. The finding that opioid tolerance studies with these ligands in mice showed no correlation with the BRET data is consistent with the absence of association of MOP and CCK 2 receptors in vivo.

UR - http://www.scopus.com/inward/record.url?scp=60549111230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60549111230&partnerID=8YFLogxK

U2 - 10.1021/jm800174p

DO - 10.1021/jm800174p

M3 - Article

C2 - 19113864

AN - SCOPUS:60549111230

VL - 52

SP - 247

EP - 258

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 2

ER -